Optimizing PTSD Treatment: PE Versus PE Plus Sertraline

Trial Profile

Optimizing PTSD Treatment: PE Versus PE Plus Sertraline

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 08 Mar 2016

At a glance

  • Drugs Sertraline (Primary)
  • Indications Post-traumatic stress disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Mar 2016 Planned End Date changed from 1 Jan 2015 to 1 Jan 2017 as reported by ClinicalTrials.gov.
    • 03 Mar 2016 Planned primary completion date changed from 1 Jan 2015 to 1 Jan 2017 as reported by ClinicalTrials.gov.
    • 03 Mar 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top